摘要 |
The invention encompasses novel pharmaceutical compositions and dosage forms of sympathetic adrenergic antagonists that are formulated for parenteral administration to a human. Also provided are methods of treating a human with the pharmaceutical compositions and dosage forms, and kits of the pharmaceutical compositions and dosage forms.
|